Disease-Specific Research Programs

The Human Microbiology Institute, aims to investigate the role of the human microbiota in these age-related cognitive diseases and utilize this information in translational research to develop novel therapeutic approaches.

The Human Microbiology Institute has already identified several novel multipotent targets for treatment of metabolic diseases and now plans to translate these discoveries into novel drugs that become available to the millions of patients that need them.